MNKD
NASDAQ
US
MannKind Corporation - Common Stock
$2.50
▼ $-0.04
(-1.57%)
Vol 3.8M
7
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.7B
P/E
60.5
ROE
-297.7%
Margin
9.2%
D/E
994.86
Beta
0.86
52W
$3–$7
Wall Street Consensus
15 analysts · Apr 20265
Strong Buy
8
Buy
2
Hold
0
Sell
0
Strong Sell
86.7%
Buy Rating
Price Chart
Similar Stocks
SANA
Sana Biotechnology Inc
$1.1B
SPRY
ARS Pharmaceuticals Inc
$1.2B
ANNX
Annexon Inc
$726.5M
JBIO
Jade Biosciences Inc
$709.8M
KURA
Kura Oncology Inc
$904.1M
VOR
Vor Biopharma Inc
$286.6M
SLS
Sellas Life Sciences Group Inc
$537.0M
MGTX
MeiraGTx Holdings PLC
$639.9M
SLDB
Solid Biosciences Inc
$439.4M
Earnings
Beat rate: 25.0%
Next Report
May 06, 2026
EPS Estimate: $0.00
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $0.00 | — | — |
| Dec 2025 | $0.01 | $-0.05 | $-0.06 |
| Sep 2025 | $0.02 | $0.07 | +$0.05 |
| Jun 2025 | $0.05 | $0.00 | $-0.05 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -297.7% | -297.7% | -297.7% | -297.7% | -297.7% |
| P/E (TTM) | 35.17 | 37.64 | 52.02 | 53.07 | 59.69 | 60.55 |
| Net Margin | 0.9% | 10.7% | 10.7% | 10.7% | 9.2% | 9.2% |
| Gross Margin | 79.1% | 77.4% | 77.4% | 77.4% | 78.5% | 78.5% |
| D/E Ratio | — | 994.86 | 994.86 | 994.86 | 994.86 | 994.86 |
| Current Ratio | 2.50 | 2.50 | 2.50 | 2.50 | 3.29 | 3.29 |
Key Ratios
ROA (TTM)
6.7%
P/S (TTM)
5.55
P/B
4.0
EPS (TTM)
$0.09
CF/Share
$-0.09
Rev Growth 3Y
+55.9%
52W High
$7.02
52W Low
$3.38
$3.38
52-Week Range
$7.02
How does MNKD compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
MNKD valuation vs Biotechnology peers
P/E ratio
60.6
▲
222%
above
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
5.6
▼
57%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
4.0
▲
64%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
MNKD profitability vs Biotechnology peers
ROE
-297.7%
▼
342%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
9.2%
▲
103%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
78.5%
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
6.7%
▲
114%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
MNKD financial health vs Biotechnology peers
D/E ratio
994.9
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
3.3
▼
26%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.9
▼
11%
below
peers
(1.0)
vs Peers
vs Industry
Less volatile
MNKD fundamentals radar
MNKD
Peer median
Industry
MNKD profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio